Waiving patent protections for COVID-19 vaccines is fiercely opposed by Big Pharma because they say it would set a precedent that could threaten future innovations, and insist the move would not speed up production.
Waiving patent protections for COVID-19 vaccines is fiercely opposed by Big Pharma because they say it would set a precedent that could threaten future innovations, and insist the move would not speed up production.
